Increase lymphocyte infiltration overcomes tumor resistance to checkpoint blockade

被引:0
|
作者
Tang, Haidong [1 ]
Wang, Yang [1 ]
Fu, Yang-Xin [1 ]
机构
[1] Univ Chicago, Chicago, IL 60637 USA
关键词
D O I
10.1158/2326-6074.CRICIMTEATIAACR15-A088
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A088
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Deactivation of ligand-receptor interactions enhancing lymphocyte infiltration drives melanoma resistance to immune checkpoint blockade
    Sahni, Sahil
    Wang, Binbin
    Wu, Di
    Dhruba, Saugato Rahman
    Nagy, Matthew
    Patkar, Sushant
    Ferreira, Ingrid
    Wang, Kun
    Ruppin, Eytan
    CANCER RESEARCH, 2024, 84 (07)
  • [12] Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
    Jeffrey J. Ishizuka
    Robert T. Manguso
    Collins K. Cheruiyot
    Kevin Bi
    Arpit Panda
    Arvin Iracheta-Vellve
    Brian C. Miller
    Peter P. Du
    Kathleen B. Yates
    Juan Dubrot
    Ilana Buchumenski
    Dawn E. Comstock
    Flavian D. Brown
    Austin Ayer
    Ian C. Kohnle
    Hans W. Pope
    Margaret D. Zimmer
    Debattama R. Sen
    Sarah K. Lane-Reticker
    Emily J. Robitschek
    Gabriel K. Griffin
    Natalie B. Collins
    Adrienne H. Long
    John G. Doench
    David Kozono
    Erez Y. Levanon
    W. Nicholas Haining
    Nature, 2019, 565 : 43 - 48
  • [13] Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
    Ishizuka, Jeffrey J.
    Manguso, Robert T.
    Cheruiyot, Collins K.
    Bi, Kevin
    Panda, Arpit
    Iracheta-Vellve, Arvin
    Miller, Brian C.
    Du, Peter P.
    Yates, Kathleen B.
    Dubrot, Juan
    Buchumenski, Ilana
    Comstock, Dawn E.
    Brown, Flavian D.
    Ayer, Austin
    Kohnle, Ian C.
    Pope, Hans W.
    Zimmer, Margaret D.
    Sen, Debattama R.
    Lane-Reticker, Sarah K.
    Robitschek, Emily J.
    Griffin, Gabriel K.
    Collins, Natalie B.
    Long, Adrienne H.
    Doench, John G.
    Kozono, David
    Levanon, Erez Y.
    Haining, W. Nicholas
    NATURE, 2019, 565 (7737) : 43 - +
  • [14] Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
    Martin, Constance J.
    Datta, Abhishek
    Littlefield, Christopher
    Kalra, Ashish
    Chapron, Christopher
    Wawersik, Stefan
    Dagbay, Kevin B.
    Brueckner, Christopher T.
    Nikiforov, Anastasia
    Danehy, Francis T., Jr.
    Streich, Frederick C., Jr.
    Boston, Christopher
    Simpson, Allison
    Jackson, Justin W.
    Lin, Susan
    Danek, Nicole
    Faucette, Ryan R.
    Raman, Pichai
    Capili, Allan D.
    Buckler, Alan
    Carven, Gregory J.
    Schurpf, Thomas
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (536)
  • [15] Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor
    Kim, Sang-Soo
    Harford, Joe B.
    Moghe, Manish
    Rait, Antonina
    Chang, Esther H.
    ONCOIMMUNOLOGY, 2018, 7 (10):
  • [16] Targeting dual gene delivery nanoparticles overcomes immune checkpoint blockade induced adaptive resistance and regulates tumor microenvironment for improved tumor immunotherapy
    Feng, Yuanji
    Wu, Jiayan
    Chen, Jie
    Lin, Lin
    Zhang, Sijia
    Yang, Zhiyu
    Sun, Pingjie
    Li, Yanhui
    Tian, Huayu
    Chen, Xuesi
    NANO TODAY, 2021, 38
  • [17] Tumor selective immunotherapy to overcome checkpoint blockade resistance.
    Jiang, Lingxiang
    Hergenrother, Paul J.
    Huang, Xiumei
    CANCER RESEARCH, 2021, 81 (13)
  • [18] Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
    Zhou, Xiaoting
    Ni, Yanghong
    Liang, Xiao
    Lin, Yi
    An, Biao
    He, Xiang
    Zhao, Xia
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [19] Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade (vol 29, pg 285, 2016)
    Tang, Haidong
    Wang, Yang
    Chlewicki, Lukasz K.
    Zhang, Yuan
    Guo, Jingya
    Liang, Wei
    Wang, Jieyi
    Wang, Xiaoxiao
    Fu, Yang-Xin
    CANCER CELL, 2016, 30 (03) : 500 - 500
  • [20] Reprogramming of tumor-induced emergency granulopoiesis overcomes immune checkpoint therapy resistance
    Tang, Hui
    Xie, Ping
    Ahn, Ji Hae
    Choi, Mi Ran
    Fan, Jie
    Orpano, Rachel
    Zhang, Bin
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):